5.72 -0.01 (-0.17%) | 02-11 16:19 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 6.77 | 1-year : | 7.91 |
Resists | First : | 5.8 | Second : | 6.77 |
Pivot price | 5.23 ![]() |
|||
Supports | First : | 4.17 | Second : | 3.16 |
MAs | MA(5) : | 5.57 ![]() |
MA(20) : | 5 ![]() |
MA(100) : | 4.71 ![]() |
MA(250) : | 8.07 ![]() |
|
MACD | MACD : | 0.3 ![]() |
Signal : | 0.3 ![]() |
%K %D | K(14,3) : | 93.7 ![]() |
D(3) : | 91.9 ![]() |
RSI | RSI(14): 70.4 | |||
52-week | High : | 17.62 | Low : | 3.16 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ NVRO ] has closed below upper band by 9.7%. Bollinger Bands are 6.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 5.74 - 5.77 | 5.77 - 5.79 |
Low: | 5.63 - 5.67 | 5.67 - 5.7 |
Close: | 5.67 - 5.72 | 5.72 - 5.77 |
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
Mon, 10 Feb 2025
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVRO, SLRN, PLYA on Behalf of Shareholders - Marketscreener.com
Mon, 10 Feb 2025
Jefferies Upgrades Nevro Corp (NVRO) to Hold - StreetInsider.com
Sat, 08 Feb 2025
Brokerages Set Nevro Corp. (NYSE:NVRO) PT at $6.30 - MarketBeat
Fri, 07 Feb 2025
Piper Sandler Upgrades Nevro (NVRO) - Nasdaq
Fri, 07 Feb 2025
Globus Medical to acquire Nevro for $5.85 per share - Yahoo Finance
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
Exchange:
NYSE
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 37 (M) |
Shares Float | 36 (M) |
Held by Insiders | 3.6 (%) |
Held by Institutions | 102 (%) |
Shares Short | 2,840 (K) |
Shares Short P.Month | 2,870 (K) |
EPS | -1.88 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 7.3 |
Profit Margin | -16.6 % |
Operating Margin | -15.7 % |
Return on Assets (ttm) | -9.1 % |
Return on Equity (ttm) | -24.8 % |
Qtrly Rev. Growth | -6.7 % |
Gross Profit (p.s.) | 7.6 |
Sales Per Share | 11.18 |
EBITDA (p.s.) | -1.96 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | -47 (M) |
Levered Free Cash Flow | -24 (M) |
PE Ratio | -3.06 |
PEG Ratio | 0 |
Price to Book value | 0.78 |
Price to Sales | 0.51 |
Price to Cash Flow | -4.57 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |